YU74601A - POSTUPAK ZA DOBIJANJE (S-(R*,S*)]-p-[[[1-OkSO-3-(4-PIPERIDINIL)PROPIL]-3-PIPERIDINIL]KARBONIL]AMINO]-3-PIPERIDINPROPIONSKE KISELINE I NJENIH DERIVATA - Google Patents
POSTUPAK ZA DOBIJANJE (S-(R*,S*)]-p-[[[1-OkSO-3-(4-PIPERIDINIL)PROPIL]-3-PIPERIDINIL]KARBONIL]AMINO]-3-PIPERIDINPROPIONSKE KISELINE I NJENIH DERIVATAInfo
- Publication number
- YU74601A YU74601A YU74601A YUP74601A YU74601A YU 74601 A YU74601 A YU 74601A YU 74601 A YU74601 A YU 74601A YU P74601 A YUP74601 A YU P74601A YU 74601 A YU74601 A YU 74601A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- piperidinepropaonic
- karbonyl
- piperidinil
- propil
- derivates
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12567199P | 1999-03-22 | 1999-03-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU74601A true YU74601A (sh) | 2004-05-12 |
Family
ID=22420863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU74601A YU74601A (sh) | 1999-03-22 | 2000-03-21 | POSTUPAK ZA DOBIJANJE (S-(R*,S*)]-p-[[[1-OkSO-3-(4-PIPERIDINIL)PROPIL]-3-PIPERIDINIL]KARBONIL]AMINO]-3-PIPERIDINPROPIONSKE KISELINE I NJENIH DERIVATA |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6515130B1 (https=) |
| EP (1) | EP1165543B1 (https=) |
| JP (1) | JP2002540108A (https=) |
| KR (1) | KR20020019895A (https=) |
| CN (1) | CN1351600A (https=) |
| AT (1) | ATE242235T1 (https=) |
| AU (1) | AU775413B2 (https=) |
| BR (1) | BR0010652A (https=) |
| CA (1) | CA2368024A1 (https=) |
| CZ (1) | CZ20013431A3 (https=) |
| DE (1) | DE60003169T2 (https=) |
| DK (1) | DK1165543T3 (https=) |
| ES (1) | ES2199805T3 (https=) |
| HK (1) | HK1046272A1 (https=) |
| HR (1) | HRP20010767A2 (https=) |
| HU (1) | HUP0201262A3 (https=) |
| MX (1) | MXPA01009615A (https=) |
| PT (1) | PT1165543E (https=) |
| SK (1) | SK13562001A3 (https=) |
| UA (1) | UA67832C2 (https=) |
| WO (1) | WO2000056730A1 (https=) |
| YU (1) | YU74601A (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2225859C2 (ru) | 1999-03-22 | 2004-03-20 | Орто-Макнейл Фармасьютикал, Инк. | Синтез 3-амино-3-арилпропаноатов |
| CA2457965C (en) * | 2001-09-21 | 2010-06-01 | Sanofi-Synthelabo | Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives |
| JP6243335B2 (ja) | 2011-08-17 | 2017-12-06 | ピラマル イメージング ソシエテ アノニム | 血小板固有の糖タンパク質ＩＩｂ／ＩＩＩａに結合する化合物と血栓造影のためのその使用 |
| CA2900595A1 (en) | 2013-02-12 | 2014-08-21 | Bayer Pharma Aktiengesellschaft | Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia |
| HRP20200437T1 (hr) | 2013-02-20 | 2020-09-04 | Reuter Chemische Apparatebau E.K. | Proces za pripremu enantiomerom obogaćenog 3-aminopiperidina |
| US20160068486A1 (en) | 2013-04-22 | 2016-03-10 | Reuter Chemische Apparatebau Kg | Process for preparing enantiomerically enriched 3-hydroxymethylpiperidine |
| KR102548998B1 (ko) | 2020-03-31 | 2023-06-29 | 재단법인 아산사회복지재단 | 혈전영상을 위한 방사성의약품 및 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE58243B1 (en) | 1983-12-07 | 1993-08-11 | Lonza Ag | A process for the preparation of optically-active 3-amino carboxylic acids |
| US5254573A (en) | 1991-10-15 | 1993-10-19 | Monsanto Company | Substituted heterocyclic derivatives useful as platelet aggregation inhibitors |
| DE69429328T2 (de) * | 1993-09-22 | 2002-06-13 | Fujisawa Pharmaceutical Co., Ltd. | N-(3-piperidinylcarbonyl)-b-alanin derivate als paf-antagonisten |
| US5770575A (en) * | 1994-03-16 | 1998-06-23 | Ortho Pharmaceutical Corporation | Nipecotic acid derivatives as antithrombotic compounds |
| EP0888302A1 (en) * | 1996-03-13 | 1999-01-07 | Fujisawa Pharmaceutical Co., Ltd. | N- (r)-1- 3-(4-piperidyl)propionyl-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist |
| ES2243996T3 (es) * | 1996-05-01 | 2005-12-01 | Ortho-Mcneil Pharmaceutical, Inc. | Derivados carboxamida de pirrolidina, piperidina y hexahidroazepina utilizados en el tratamiento de trastornos de trombosis. |
| EP0912495B1 (en) | 1996-07-12 | 2001-11-21 | G.D. SEARLE & CO. | Asymetric synthesis of chiral beta-amino acids |
| US6066651A (en) * | 1997-10-29 | 2000-05-23 | Ortho-Mcneil Pharmaceutical, Inc. | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders |
-
2000
- 2000-03-21 BR BR0010652-6A patent/BR0010652A/pt not_active IP Right Cessation
- 2000-03-21 HR HR20010767A patent/HRP20010767A2/hr not_active Application Discontinuation
- 2000-03-21 DE DE60003169T patent/DE60003169T2/de not_active Expired - Fee Related
- 2000-03-21 ES ES00916573T patent/ES2199805T3/es not_active Expired - Lifetime
- 2000-03-21 AU AU37661/00A patent/AU775413B2/en not_active Ceased
- 2000-03-21 WO PCT/US2000/007462 patent/WO2000056730A1/en not_active Ceased
- 2000-03-21 UA UA2001096538A patent/UA67832C2/uk unknown
- 2000-03-21 PT PT00916573T patent/PT1165543E/pt unknown
- 2000-03-21 CA CA002368024A patent/CA2368024A1/en not_active Abandoned
- 2000-03-21 MX MXPA01009615A patent/MXPA01009615A/es unknown
- 2000-03-21 EP EP00916573A patent/EP1165543B1/en not_active Expired - Lifetime
- 2000-03-21 CZ CZ20013431A patent/CZ20013431A3/cs unknown
- 2000-03-21 AT AT00916573T patent/ATE242235T1/de not_active IP Right Cessation
- 2000-03-21 HU HU0201262A patent/HUP0201262A3/hu unknown
- 2000-03-21 JP JP2000606591A patent/JP2002540108A/ja active Pending
- 2000-03-21 HK HK02107463.1A patent/HK1046272A1/zh unknown
- 2000-03-21 CN CN00807617A patent/CN1351600A/zh active Pending
- 2000-03-21 SK SK1356-2001A patent/SK13562001A3/sk unknown
- 2000-03-21 DK DK00916573T patent/DK1165543T3/da active
- 2000-03-21 US US09/532,375 patent/US6515130B1/en not_active Expired - Lifetime
- 2000-03-21 YU YU74601A patent/YU74601A/sh unknown
- 2000-03-21 KR KR1020017012100A patent/KR20020019895A/ko not_active Withdrawn
-
2002
- 2002-02-22 US US10/081,289 patent/US20020137937A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HK1046272A1 (zh) | 2003-01-03 |
| DK1165543T3 (da) | 2003-09-29 |
| EP1165543B1 (en) | 2003-06-04 |
| HU0201262D0 (https=) | 2002-05-29 |
| AU775413B2 (en) | 2004-07-29 |
| CZ20013431A3 (cs) | 2003-04-16 |
| DE60003169D1 (de) | 2003-07-10 |
| ATE242235T1 (de) | 2003-06-15 |
| JP2002540108A (ja) | 2002-11-26 |
| WO2000056730A1 (en) | 2000-09-28 |
| BR0010652A (pt) | 2002-07-16 |
| CA2368024A1 (en) | 2000-09-28 |
| HRP20010767A2 (en) | 2002-12-31 |
| MXPA01009615A (es) | 2003-07-21 |
| ES2199805T3 (es) | 2004-03-01 |
| SK13562001A3 (sk) | 2002-08-06 |
| HUP0201262A2 (en) | 2002-08-28 |
| US6515130B1 (en) | 2003-02-04 |
| DE60003169T2 (de) | 2005-10-27 |
| AU3766100A (en) | 2000-10-09 |
| US20020137937A1 (en) | 2002-09-26 |
| UA67832C2 (uk) | 2004-07-15 |
| HUP0201262A3 (en) | 2003-12-29 |
| EP1165543A1 (en) | 2002-01-02 |
| CN1351600A (zh) | 2002-05-29 |
| PT1165543E (pt) | 2003-10-31 |
| KR20020019895A (ko) | 2002-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60009511D1 (de) | Nematizide trifluorbutene | |
| AP1614A (en) | New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents. | |
| MX338829B (es) | Metodo para preparar 3-halo-4,5-dihidro-1h-pirazoles. | |
| DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
| ATE266013T1 (de) | 1-phenyl-4-benzylpiperazine: spezifische liganden für den dopamin rezeptor (d4) | |
| WO2001014330A3 (en) | Phenylpiperazines as serotonin reuptake inhibitors | |
| NZ516599A (en) | 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands | |
| PT1222159E (pt) | Intermediarios de fabricacao de um derivado de tipo benzofurano ou benzotiofeno nitrado em posicao 5 e as suas utilizacoes | |
| MD383C2 (ro) | Procedeu de obţinere a piperazinilalchil-3(2H)-piridazinonelor sau sărurilor lor farmaceutic admisibile | |
| YU74601A (sh) | POSTUPAK ZA DOBIJANJE (S-(R*,S*)]-p-[[[1-OkSO-3-(4-PIPERIDINIL)PROPIL]-3-PIPERIDINIL]KARBONIL]AMINO]-3-PIPERIDINPROPIONSKE KISELINE I NJENIH DERIVATA | |
| ES2185459A1 (es) | Procedimiento para la obtencion de pantoprazol y compuestos intermedios para el mismo. | |
| DE60112091D1 (de) | Verfahren zur herstellung von azacycloalkanoylaminothiazolen | |
| MX9804828A (es) | Benzotiazolona etanaminas biologicamente activas. | |
| IN187760B (https=) | ||
| DE59712632D1 (de) | Verfahren zur herstellung von 3-pyrrolin-2-carbonsäure-derivaten | |
| MXPA02001406A (es) | Heterociclilos-2h-cromenos substituidos. | |
| DE60043228D1 (de) | Herstellungsverfahren von 2-cyanopyridinen | |
| MXPA04005838A (es) | Nuevos compuestos de benzotiazina y benzotiadiazina un proceso para su prepacion y las composiciones farmaceuticas que los contienen. | |
| WO2002051845A3 (en) | Triazolopyrimidines | |
| HUP0104045A2 (hu) | Eljárás 4-[(2',5'-diamino-6'-halogén-pirimidin-4'-il)-amino]-ciklopent-2-enilmetanol-származékok előállítására | |
| DE60031315D1 (de) | Verfahren zur Herstellung von Derivaten von i(1,5-Diaryl)pyrazol-3-ylöpropansäure | |
| EA200100155A2 (ru) | Новые производные 6-амино или 6-гидразиносульфонил-3-хинолинилфосфоновой кислоты, способ их получения и содержащие их фармацевтические композиции | |
| DE50203367D1 (de) | Verfahren zur herstellung von orthocarbonsäuretrialkylestern | |
| DE60029493D1 (de) | Neues verfahren zur herstellung von 1-phenyl-2-(2-pyridyl)ethanamin | |
| DE69818431D1 (de) | Verfahren zur herstellung von 3-cyanopyridin aus 2-methyl-1,5-pentandiamin |